Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice |
| |
Authors: | Espino Ana M Osuna Antonio Gil Ramón Hillyer George V |
| |
Affiliation: | Laboratory of Molecular Parasitology and Immunology, Department of Microbiology, University of Puerto Rico, School of Medicine. aespino@rcm.upr.edu |
| |
Abstract: | The humoral and cellular responses to DNA vaccination of BALB/c mice with a novel antigen from the Fasciola hepatica saposin-like protein family (FhSAP-2) have been investigated. Two constructs were produced containing the FhSAP-2 DNA sequence, one intended for extracellular secretion of FhSAP-2 protein, and one expressing FhSAP-2 in the cytoplasm of a transfected cell. The constructs were tested in HEK 293T cells, with the secretory construct producing less detectable FhSAP-2 relative to cytoplasmic construct when observed by fluorescence. The size of expressed protein was confirmed by Western blot of cell lysate, but FhSAP-2 was undetectable in cell supernatants. Both, secretory and cytoplasmic constructs as well as FhSAP-2 recombinant protein were tested in mice. The antibody response elicited in mice vaccinated with the rFhSAP-2 induced high levels of IgG(1), IgG(2), and IgE as well as high levels of IL-10 and IFNgamma indicating a mixed Th1/Th2 response. Vaccination of mice intramuscularly with the cytoplasmic FhSAP-2 construct resulted in a dominant IgG(2a) isotype antibody as well as a dominant IFNgamma cytokine, with significant IgE, IgG(1), and IL-10 responses also present, suggesting a mixed Th1/Th2 profile. Isotype and cytokine profiles elicited by the FhSAP-2 secretory construct were similar to those obtained with the cytoplasmic construct but at levels that were significantly lower. The results demonstrate that FhSAP-2 can be delivered as a DNA vaccine construct and induces a stronger Th1 response than the recombinant protein alone. This could result in an improvement in the immunoprophylactic potential of this candidate vaccine against F. hepatica. |
| |
Keywords: | Fasciola hepatica saposin-like protein family Trematode Humoral and cellular response DNA vaccination FhSAP-2, Fasciola hepatica saposin-like protein IL-10, interleukin 10 IFNγ, γ interferon Th1, T-helper cell response type-1 Th2, T-helper cell response type-2 NK, natural killer CMV, cytomegalovirus DBB, denaturing binding buffer PCR, polymerase chain reaction LB, Luria broth E. coli, Escherichia coli SDS, sodium dodecyl sulfate EDTA, ethylenediaminotetracetic acid DNA, deoxyribonucleic acid PBS, phosphate-buffered saline Con A, Concanavalin A ELISA, enzyme linked immunosorbent assay IFA, immunofluorescence assay IM, intramuscular TPA, tissue plasminogen activator GST, glutathione S-transferase CatL, cathepsin L MHC, major histocompatibility complex PMSF, paramethylsulfonilfluoride HP, high performance |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|